73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Tennis legend Martina Navratilova diagnosed with throat, breast cancer

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this
Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

byUniversity of TsukubaCredit: AI-generated imageThe location where cancer patients spend their last days can affect their "quality of death." However, it remains unclear whether the l

Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

byUniversity of TsukubaCredit: AI-generated imageThe location where cancer patients spend their last days can affect their "quality of death." However, it remains unclear whether the l
Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h
Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich
Team develops effective cigar warning signage

Team develops effective cigar warning signage

byUniversity of North Carolina at Chapel Hill School of MedicineStimuli for the experimental conditions. Participants saw an image of a cigar store countertop at the point-of-sale with randomiza

Team develops effective cigar warning signage

byUniversity of North Carolina at Chapel Hill School of MedicineStimuli for the experimental conditions. Participants saw an image of a cigar store countertop at the point-of-sale with randomiza
Team develops tools and techniques to explore cancer signals at the subcellular level

Team develops tools and techniques to explore cancer signals at the subcellular level

by Jerry Grillo,Georgia Institute of TechnologyGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104980This year, about 240,000 people in the U.S. will discover the

Team develops tools and techniques to explore cancer signals at the subcellular level

by Jerry Grillo,Georgia Institute of TechnologyGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104980This year, about 240,000 people in the U.S. will discover the
Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainA collaborative group led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the Univers

Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainA collaborative group led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the Univers
Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers
Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

by Impact Journals LLCFigure 1 (truncated): Idh2R140Q/NHD13 double transgenic mice develop EITP ALL resembling the human disease. Credit: 2022 Negi and AplanA new research perspective titled "A m

Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

by Impact Journals LLCFigure 1 (truncated): Idh2R140Q/NHD13 double transgenic mice develop EITP ALL resembling the human disease. Credit: 2022 Negi and AplanA new research perspective titled "A m
Team successfully generates mouse models for two subtypes of multiple myeloma

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl

Team successfully generates mouse models for two subtypes of multiple myeloma

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineLeft: Normal bone marrow in the control animals with stained myeloid cells. Right: Bone marrow in the transgenic animals with pl